Enzymotec Ltd. To Present at Two Upcoming Investor Conferences

MIGDAL HA'EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq: ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.

Details for the Company presentation are as follows:

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health.  For more information, visit www.enzymotec.com.

Contact:

The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
[email protected]
[email protected]

You May Also Be Interested In

• Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
• New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
• The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine